SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
936 Arnie & Shadow If there is enough tax loss selling pressure to drop PARS beStephen D. Wilson-10/26/1999
935 Check the following link, is about BLA, but probably very similar to NDA (dexanCacaito-10/25/1999
934 Shadow: Thanks for adding to my note about delisting. The price is probably undarnie h-10/25/1999
933 Re:delisting NASDQ looks at other issues aside from stock price alone. A compaShadow-10/23/1999
932 There are some on the Yahoo thread who are concerned about delisting if the priarnie h-10/23/1999
931 Do you know Alcon's market share? Rick Strange-10/20/1999
930 Lets see if PARS BOL can capitalize on this. competition gets a recall Novembyosi s-10/20/1999
929 Damn! I went on the wagon about five years ago and now I find out I have given Rick Strange-10/14/1999
928 Prophylactic use of Irish Coffee soars... replaces air bags and helmets as #1RWReeves-10/14/1999
927 I just heard a report on a major radio station in New York that research has shThomas M. Carroll-10/14/1999
926 Cacaito: <Position: I am a holder, this is a high risk investment, not buyiarnie h-10/13/1999
925 Neuroinvest stated, in his news letter that mortality in cohort 3 is less oryosi s-10/12/1999
924 Cacaito, are the mortality numbers that you are using in the prior post only frRick Strange-10/12/1999
923 Mortality decrease was good: down 28%, problem is the low number of subjects. Cacaito-10/11/1999
922 Cacaito, Many questions: Is the 300 trial size large enough for approval. Ischadenfreude-10/11/1999
921 <Pharmos is moving alone with Phase III> You have to admire they're LLCF-10/11/1999
920 Pharmos is moving alone with Phase III. Good, to wait for partner is to waste Cacaito-10/11/1999
919 Wow, insiders continue to buy eh???? Interesting. DAK LLCF-10/7/1999
918 Bloomberg has long interview with Aviv, who predicts profitabily next year. NoLLLefty-10/6/1999
917 From the Yahoo board: Pharmos news: by: kfarblum Zvi Steinberg-10/5/1999
916 Dr. Tracy (Neuroinvestor) wrote, here or at Yahoo, that the FDA wants to see atRick Strange-10/5/1999
915 <<LE-tobramicin should bring both milestones, licensing, royalties paymenStephen D. Wilson-10/5/1999
914 More examples: ICOS, and SEPR: ICOS is well capitalized from inception, Bill GCacaito-10/5/1999
913 Love it! Some positive vibes... hopefully it helps. <Let the market stagnLLCF-10/4/1999
912 <IMO it's a new paradigm now... the convert is gone, so are the short searnie h-10/4/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News